Intraoperative assessment of ureter perfusion after revascularization of transplanted kidneys using intravenous indocyanine green fluorescence imaging.

BACKGROUND: Kidney transplantation is the most valuable renal replacement therapy. One of the most common urologic complications following kidney transplantation is ureter anastomosis leakage, which leads to high morbidity along with kidney graft loss. We hypothesized that indocyanine green (ICG) fluorescence videography can assess ureter perfusion after revascularization of transplanted kidneys.
METHODS: We conducted a prospective cross-sectional study in end-stage renal disease patients who underwent deceased donor kidney transplantation at Ramathibodi Hospital from September 2019 to January 2020. The segments of transplanted ureters were categorized as having good or poor perfusion based on the percentage from ICG fluorescence videography images. Then the results from ICG fluorescence videography were compared with histopathology which is considered the gold standard.
RESULTS: Thirty-one sections of dissected ureters were evaluated from 10 patients. Compared with pathological diagnosis of ureteral ischemia, ICG videography had sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and positive likelihood ratio of 100%, 92.6%, 66.7%, 100%, and 14, respectively. Accuracy was 93.6%. The area under the curve of ICG fluorescence videography was 0.96. The average ureter length that maintained good perfusion was 14 cm from the ureteropelvic junction. Adverse events from ICG were not observed in this study.
CONCLUSIONS: We conclude that ICG fluorescence videography is beneficial for detection of early ureteral ischemia in kidney transplantation patients, with negligible adverse events. However, further studies with larger numbers of patients are necessary to confirm our results and clinical outcomes regarding complication rates. 2021 Translational Andrology and Urology. All rights reserved.

Introduction

Chronic kidney disease (CKD) ranks among the most common diseases and negatively affects quality of life and life expectancy. Based on the registry from Asian-Pacific, Australian and New Zealand, Canada, Europe, Japan and United States, the prevalence of CKD has increased by 29.3% since 1990 (1,2). KT is the most cost-effective procedure for renal replacement therapy which was found to be performed around 69,400 KTs annually worldwide. Among them, 64% were from deceased donors (3). Compared with dialysis, KT reduces the risk of death by over 60%, doubles expected survival time, and greatly improves quality of life (4).

Urological complications in KT recipients remain common. Complications such as urine leakage, ureteral stenosis, lymphocele, lithiasis, urethral stricture, and vesicoureteral reflux are reported in recipients with incidence of 2.5–30% (5). One of the most common urologic complications following KT is ureter anastomosis leakage, which leads to high morbidity along with kidney graft loss. At Ramathibodi Hospital, the incidence of urinary leakage complications was reported as roughly 4.4% (6). Compromising blood supply to the distal ureter during organ procurement is the primary risk factor for ureteral necrosis and urinary leakage, and can lead to high morbidity and kidney graft loss (7,8). Following vascular anastomosis during KT, assessing the quality of the ureter is an important step, although it remains difficult to properly evaluate and can be problematic in some patients. Owing to the anatomical features of the ureter, the branches of its arteries are small and are easily injured because of tearing (9). Currently, no accurate method exists for diagnosing vascular compromise of the ureter, necessitating an attempt to identify a method for assessing the ureter during KT by determining the area of the ureter that has insufficient blood supply before ureter anastomosis is performed (7,8,10).

Indocyanine green (ICG) is widely used for evaluating function and perfusion after various procedures, such as free flap surgery and assessing burn depth (11). The applicability and potential advantages of ICG fluorescence during organ transplantation are limited and incompletely understood. In liver and pancreas transplantations, ICG is used to assess graft bile duct perfusion and the perfusion level of the duodenal graft stump for identifying perfusion defects that may be transected before anastomosis (12,13). Furthermore, fluorescence angiography with ICG allows intraoperative quantitative assessment of delayed graft function during kidney transplantation (14). According to a previous report, the use of ICG fluorescence videography is a valuable adjunctive modality in intraoperative monitoring of free flap surgeries and kidney graft function, and appears to be a sensible tool for detecting compromised microcirculation (15). Because of the basic pharmacokinetic and pharmacodynamic properties of tricarbocyanine dye, most ICG is distributed exclusively in blood vessels. Furthermore, ICG has a short half-life and is rapidly eliminated without enterohepatic and urinary circulation (16). Additionally, images can be obtained relatively quickly using this process. ICG has also been found to induce a low incidence of adverse reactions and is considered safe. However, on the basis of previous studies, information on using ICG primarily for assessing ureteral viability during KT is limited (17).

With the aim of preventing complications associated with ureteral necrosis, we hypothesized that ICG fluorescence videography could accurately assess ureter perfusion following vascular anastomosis (11,18). The objective of this study was to evaluate the accuracy of ICG fluorescence imaging in the diagnosis of hypoperfusion of transplanted ureters, while comparing it with pathological evidence of ureteral ischemia, which is the gold standard diagnostic method. Because of limited knowledge on the effect of ureteral length on urological complications after KT, our secondary objective was to estimate the average ureter length that maintains good perfusion before performing ureteral reimplantation using fluorescence imaging. Finally, we evaluated the safety of ICG in patients with ESRD. We present the following article in accordance with the STARD reporting checklist (available at http://dx.doi.org/10.21037/tau-21-160).

Methods

Study population

After ethical approval from the Committee on Human Rights Related to Research involving Human Subjects, Faculty of Medicine, Ramathibodi Hospital (No. MURA2018/405), we conducted a cross-sectional study with all ESRD patients who underwent deceased donor kidney transplantation (DDKT) from September 2019 to January 2020. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). Inclusion criteria were male and female ESRD patients aged over 18 years admitted to the hospital for DDKT. We excluded patients with history of ICG or iodine allergy, poor liver function, and those who refused to participate in the study. When the patients were admitted for the DDKT, written informed consent was obtained from all participants and patients’ anonymities were preserved. We reviewed the database containing information on the patients. Baseline features and perioperative data including age, sex, cold ischemic time, and recipient warm ischemic time were collected.

The study flow diagram is shown in . Patients who met the inclusion criteria underwent DDKT as a standard procedure. Kidney graft was prepared, preserving in Euro-Collins solution and renal vessels and ureter were identified. After that, kidney graft was perfused and vascular anastomosis was subsequently performed using external iliac artery and vein. Ten minutes after vascular anastomosis was completed, a single dose of ICG (Diagnogreen® Injection, Daiichi Sankyo Propharma, Japan) was injected intravenously. The dose of ICG was 0.25 mg/kg body weight (13,17), and the maximum dose was 12.5 mg, which was decreased from the amount used in ICG videography for other indications based on renal function. Fluorescent videography (Fluoptic, Fluobeam® 800 Clinical System, Parvis Louis Néel, CS 20050 38040 Grenoble Cedex 9, France) was then used to evaluate ureter perfusion, and was shown as the spectrum of color along with the percentage of perfusion. Digital photographs and video recordings of the area were captured until 5 min after ICG injection. The picture with maximal perfusion, which was defined as the picture when the perfusion colour persisted, was used for the analysis. Quantification of perfusion was then performed on the saved images after completing the operation. The assessor was blinded from the histopathology result. All patients were performed antirefluxing extravesical ureteroneocystostomy using Lich-Gregoir technique. The ureter was anastomosed to the bladder mucosa using maxon 4-0. The seromuscular layer was closed over the ureter creating the tunnel with chromic 3-0. Foley catheter was placed for 7 days and ureteral stent was placed for 14 days. Perioperative outcomes were recorded, including time to visualize ureter perfusion, and ureter length. Adverse events from ICG were monitored during and after the procedure (16,19,20).

Figure 1

Flow chart of the study procedure.

On the basis of ICG images, segments of transplanted ureters were categorized as having good or poor perfusion. Good ureteral perfusion was defined based on results from ICG videography, and showed a perfusion percentage of over 25%, corresponding to the colors green, yellow, and red. In contrast, a perfusion percentage less than 25% indicated poor perfusion, corresponding to the color blue (21). A single interrupted 5-0 Maxon suture was placed at the transformation point and the junction was marked between each percentage of perfusion (75%, 50%, and 25%) and cut separately for pathological examination. Tissue was then sent for histopathological analysis. Ureter segments were evaluated histopathologically using an electron microscope within 24 hours after surgery. All specimens were evaluated by an experienced uropathologist who had specialized in KT for over 5 years. The pathologist was blinded to the results of ICG videography, and histopathological results were reported as normal or ischemic ureter. An ischemic ureter was defined as the observation of multiple focal denudations of urothelial cells that were distinguishable from traumatic tissue injury.

The primary outcome was the accuracy of ICG fluorescence videography. The gold standard diagnostic tool used in this study was histopathology. The secondary outcome was the average ureter length that maintained good perfusion before performing ureteral reimplantation using fluorescent imaging. The length of the viable ureter was measured from the ureteropelvic junction to the distal cut ureter. Finally, we evaluated adverse events from ICG, which can include anaphylaxis, anaphylactoid reaction, significant nausea or vomiting, and dizziness (19,20).

Statistical analysis

Due to this was an initial study of the test, only 10 patients were included into our study. Missing data of the test were not expected because of the cross-sectional study design. Data pertaining to baseline features of patients and the procedure were presented as percentage or mean ± standard deviation (SD). Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (+LR), negative likelihood ratio (−LR), and accuracy were analyzed. The test of equality of area under the receiver operating characteristic curve was used to determine differences in terms of accuracy. Statistical analyses were performed using Stata version 14, and P<0.05 was considered statistically significant.

Results

Ten patients met the inclusion criteria and were therefore eligible for the study. Flow of participants is shown in . Seven patients (70%) were male, and mean age was 45.8 years, with SD of 5.55. Mean cold ischemic time was 1,057.1 min, with SD of 239.54 min, while mean warm ischemic time was 43.2 min, with SD of 8.4 min. Regarding the donors, 8 were male and 2 were female. Mean age of the donor was 29.2 years old, with SD of 14.46 years old. Details on demographic parameters and perioperative outcomes are shown in .

Figure 2

Flow of participants.

Table 1

Demographic data and perioperative outcomes

Parameter	Total (n=10)
Sex, n (%)
Male	7 (70%)
Female	3 (30%)
Age (years), mean ± SD	45.80±5.55
Cold ischemic time (min), mean ± SD	1,057.10±239.54
Recipient warm ischemic time (min), mean ± SD	43.20±8.40
Initial ureter length after vascular anastomosis (cm), mean ± SD	16.20±2.25
Cut ureter before reimplantation (cm), mean ± SD	11.15±1.25
Dissected ureter for pathology (cm)*, mean ± SD	5.05±1.86
Time to first visualize ureter perfusion (sec.), mean ± SD	15.0±6.63
Time to visualize high ureter perfusion (sec.), mean ± SD	126.0±54.2
Perfused ureter length at thigh (cm), mean ± SD	12.75±1.49
Time to visualize maximal ureter perfusion (sec.), mean ± SD	187.0±45.71
Perfused ureter length at Tmax (cm), mean ± SD	14.0±2.13

*Dissected ureter for pathology was calculated from the difference in length between the initial ureter length after vascular anastomosis and the cut ureter before ureteroneocystostomy. SD, standard deviation.

Thirty-one segments of dissected ureters from the 10 patients were evaluated and compared with a pathological diagnosis of ureteral ischemia. A representative image from ICG videography is shown in . A diagram showing the results of ICG fluorescence videography for each patient is shown in .

Figure 3

Imaging from paired structures identified in both monochrome (left) and multicolor (right) phases from before ureter anastomosis in the same patient.

Figure 4

Ureter perfusion diagram by indocyanine green fluorescence videography.

ICG videography had sensitivity, specificity, PPV, NPV, and +LR of 100%, 92.6%, 66.7%, 100%, and 14, respectively. Accuracy was 93.6% (). The area under the curve of ICG fluorescence videography was 0.96 (). The average ureter length that maintained good perfusion was 14 cm from the ureteropelvic junction. Adverse events from use of ICG, such as anaphylaxis, anaphylactoid reaction, significant nausea or vomiting, and dizziness, were not observed. Regarding kidney graft function, one patient (number 5 in ) experienced vascular thrombosis leading to graft loss, and underwent nephrectomy at 26 days after the operation.

Table 2

Sensitivity, specificity, positive predictive values, negative predictive values, and accuracy

Pathology	ICG Videography		Total	Sensitivity	Specificity	PPV	NPV	Accuracy
	Positive	Negative
Positive	4	0	4	100%	92.6%	66.7%	100%	93%
Negative	2	25	27
Total	6	25	31

Figure 5

Receiver operating characteristic curve for predicting early ureteral ischemia using indocyanine green fluorescence videography.

Discussion

The incidence of urinary leakage following KT in our hospital was reported as 4.4% (6). This complication is associated with significant morbidity (including prolonged hospital stay and graft loss) and mortality. Risk factors include graft devascularization during organ procurement, imprudent dissection, unskilled suturing, or prolonged cold ischemic time. Other factors that may contribute to development of urological complications after KT are graft-related, such as ureteral vascularization and arterial multiplicity. Distal ureteral ischemia and necrosis secondary to compromised blood supply are believed to be the main causes of early ureteral complications in most patients in the absence of technical difficulties during surgery. Transplanted ureters depend solely on blood supplied by the branches of the renal artery that traverse periureteric tissues. This area is also known as the golden triangle. Indeed, the importance of preserving periureteral connective tissue to prevent disastrous urinary complications is well documented (5,7-10). We believe that gentle manipulation of the ureter and adequate preservation of periureteral tissue, while properly maintaining the length of the ureter without tension, are of key importance. A ureter with ischemic appearance after reperfusion should be resected until a good area of perfusion is achieved (22-25).

In DDKT, it remains difficult to evaluate whether transplanted ureters are sufficiently perfused. In current practice, assessment of ureter viability depends on visualization by the surgeon, which is a subjective measurement and requires the surgeon to have sufficient experience. Furthermore, renal transplantation after ex vivo normothermic perfusion (EVNP) (26) was recently introduced in clinical practice using an EVNP circuit designed to deliver an oxygenated, warmed, red cell-based perfusate to the kidney. Creating a clear line of demarcation between a well-vascularized renal pelvis and proximal ureter and a distal ureter that appears to completely lack a blood supply, allows the ureter to be marked and transected at a point where the blood supply is deemed optimal. It should be noted that EVNP provides additional information on the adequacy of the ureteral blood supply before revascularization in the recipient (27). However, EVNP has long been costly and limited availability.

ICG is a molecule with mass of 776 Daltons that was approved for clinical use in 1959 by the Food and Drug Administration. It has been used in medicine since the late 1950s to assess liver function before major liver resections in cirrhotic patients (28). The applicability of fluorescence in the diagnosis of hepatic tumors such as hepatocellular carcinomas was initially described in a report from Japan. Moreover, fluorescence has been extensively employed in gynecological, endocrinological, and colorectal surgeries (29-31). However, the applicability and potential advantages of using ICG fluorescence during organ transplantation are limited and incompletely understood. Fluorescent imaging can clearly visualize reconstructed vessels in living donor liver transplantations, kidney allograft perfusion, and renal vasculature after revascularization of transplanted kidneys. Rother et al., found that fluorescence angiography reflects preexisting morphological changes of the renal cortex which may serve as a method for the assessment of microperfusion of the kidney allograft (32). Siddighi et al. reported that intraurethral injection of ICG and visualization under near-infrared light allow for real-time delineation of the ureter (33). Lee et al. found that intraurethral injection of ICG and subsequent visualization under near-infrared fluorescence facilitates robot-assisted ureteral reconstructions by aiding in rapid and accurate identification of the ureter and precise localization of the proximal and distal ureteral stricture margins (34).

The role of ICG fluorescence videography in intraoperative assessment of ureter perfusion after revascularization of a transplanted kidney, still remains questionable. Vignolini et al. reported the first preliminary experience with intraoperative ICG fluorescence videography for assessing graft and ureteral reperfusion during robot-assisted KT, and concluded that ICG provides a reliable assessment of graft reperfusion. However, larger studies are required to standardize the technique (35). Herein, we present our initial experience with ICG fluorescence videography for evaluating ureter perfusion during DDKT.

Our results showed that ICG fluorescence videography allows for high sensitivity and specificity in differentiating between normoperfused and hypoperfused segments of transplanted ureters. Compared with histopathology, the gold standard diagnostic method, the accuracy of ICG was over 90%.

One patient in our cohort exhibited a large perfusion deficit in the kidney graft after initial positioning in the iliac fossa. After reperfusion, the graft was suspected of homogeneous impaired perfusion. However, this patient experienced vascular thrombosis that ultimately led to graft loss and was required to undergo nephrectomy within the subsequent 3 weeks. There were no complications with ICG injection or the video-imaging device. No adverse events from ICG were observed in our study. However, the safety of ICG cannot be concluded because our study had a small number of patients. Larger study with adverse event assessment will be required.

The strength of our study was that all participants underwent both the index test and pathological examination of ureters, which is considered the gold standard for diagnosis. These examinations eliminate verification bias. However, our study also had limitations. First, the number of participants was small and our study can be considered a pilot study. Larger studies are required to standardize the technique and to evaluate the association between perioperative parameters and acute ureteral ischemia. Second, we measured ureteral ischemia, which is considered a surrogate outcome rather than a clinical outcome of ureteral necrosis or anastomosis leakage. Further studies evaluating clinical outcomes are therefore warranted. Finally, regarding technical issues, the psychomotor skills of users, including the distance and angle from camera to targeted ureter, may affect the interpretation of results. Interobserver variation should also be further validated.

In our study, ICG fluorescence videography provided reliable and relevant additional information to surgeons for guiding intraoperative decisions in DDKT without adverse events, and should be used as an adjunct to clinical assessments in cases with ureters with an indeterminate state of perfusion.

Conclusions

ICG fluorescence videography is beneficial for the detection of early ureteral ischemia in DDKT patients with negligible complications because it is minimally invasive and displays high accuracy. However, further studies with larger numbers of patients and follow-up for clinical outcomes are necessary to further validate our results.

The article’s supplementary files as